Trump announces 100% tariff on imports of branded or patented pharmaceuticals from October 1

Core Viewpoint - The United States will implement a 100% tariff on imports of branded or patented pharmaceutical products starting October 1, unless the pharmaceutical company is establishing a manufacturing facility in the U.S. [1] Group 1 - The tariff is aimed at encouraging pharmaceutical companies to invest in U.S. manufacturing [1] - This policy reflects the administration's broader strategy to promote domestic production and reduce reliance on foreign imports [1] - The announcement was made by President Donald Trump, indicating a significant shift in trade policy towards the pharmaceutical industry [1]